EFFECTS OF TAURINE AND GUANIDINOETHANE SULFONATE ON TOXICITY OF THE PYRROLIZIDINE ALKALOID MONOCROTALINE

Citation
Cc. Yan et Rj. Huxtable, EFFECTS OF TAURINE AND GUANIDINOETHANE SULFONATE ON TOXICITY OF THE PYRROLIZIDINE ALKALOID MONOCROTALINE, Biochemical pharmacology, 51(3), 1996, pp. 321-329
Citations number
57
Categorie Soggetti
Pharmacology & Pharmacy",Biology
Journal title
ISSN journal
00062952
Volume
51
Issue
3
Year of publication
1996
Pages
321 - 329
Database
ISI
SICI code
0006-2952(1996)51:3<321:EOTAGS>2.0.ZU;2-J
Abstract
Monocrotaline (MONO), a pyrrolizidine alkaloid, causes pulmonary arter ial hypertension and right ventricular hypertrophy due to hepatic meta bolism to the alkylating pyrrole dehydromonocrotaline. Taurine, a sulf onic amino acid, is hepato- and cardioprotective in a variety of condi tions. We have examined the effects of taurine and its amidino analog, guanidinoethane sulfonate (GES), in rats injected i.p. with MONO (65 mg/kg). Taurine and GES were given as 1% solutions in drinking water b eginning 14 days before administration of MONO and continuing for 14 d ays thereafter, when the rats were killed. The MONO group had right ve ntricular hypertrophy and pulmonary hyperplasia. Compared with control , no significant changes in the right ventricle/left ventricle weight ratio, or the right ventricle/body weight ratio occurred in rats also given taurine or GES. Lung weights in these two groups were higher tha n in the control group, but below that of the MONO-alone group. The le thality of MONO over 14 days was decreased by taurine (LD(50) for MONO alone 80 mg/kg; for MONO + taurine 121 mg/kg). Rats given only MONO h ad lower hepatic concentrations of GSH and cysteine (Cys), and higher activities of microsomal GSH transferase and gamma-glutamyl transpepti dase. In rats also receiving taurine, hepatic GSH levels and GSH trans ferase activity were no different from control. gamma-Glutamylcysteine (Glu-Cys) synthetase and gamma-glutamyl transpeptidase activities wer e elevated. In MONO-injected rats given GES, hepatic GSH levels were h igher and Cys levels were lower than in either the MONO alone or MONO + taurine groups. gamma-Glu-Cys synthetase activity was depressed. Mic rosomal GSH transferase, GSH peroxidase and gamma-glutamyl transpeptid ase activities were elevated. Livers of MONO-injected animals showed h igher levels of serine (reversed by both taurine and GES) and glycine (Gly; reversed by GES) and lower levels of glutamine. Compared with co ntrol rats, the following changes occurred in serum amino acids: MONO alone: increased aspartate, taurine and lysine; taurine-supplemented: increased taurine, methionine (Met) and lysine, and decreased Gly; GES -supplemented: decreased asparagine, serine, Gly, arginine, taurine, a nd valine. Compared with the MONO-alone group, the taurine-supplemente d group had higher glutamate (Glu), Met and alanine, and the GES-suppl emented group higher alanine and lower serine, Gly, arginine and valin e. We conclude that taurine protects against MONO-induced lethality an d right ventricular hypertrophy. GES also protects against right ventr icular hypertrophy. However, these agents act by different mechanisms, taurine preventing many of the biochemical changes induced by MONO, w ith GES inducing additional changes.